Joint Satellite - Myometrium/Parturition/Preterm Birth International Collaborative (PREBIC) Satellite Meeting
Wednesday, March 11, 2020 - Vancouver, BC, Canada
East Meeting Room 8&15 - Vancouver Convention Centre East, Level 2
PREBIC Organizer:
Ramkumar Menon, PhD
Associate Professor, Department of Obstetrics and Gynecology
The University of Texas Medical Branch at Galveston, Galveston, TX, USA
Executive Director – PREBIC
Parturition/Myometrium Organizer:
Rachel Tribe, PhD
Professor of Maternal and Perinatal Science, Department of Women and Children’s Health
King’s College London, London, United Kingdom
Session I Moderators: Cynthia Gyamfi-Bannerman, MD |
||
8:20 a.m. – 8:30 a.m. |
Preterm Birth International Collaborative Activities |
|
8:30 a.m. - 9:00 a.m. |
Pursuit of New Tools for Addressing Adverse Pregnancies and Newborn Complications in Global Health |
|
9:00 a.m. - 9:30 a.m. |
Risks Associated With Viral Infections During Pregnancy |
|
9:30 a.m. - 10:00 a.m. |
BREAK |
|
Session II Moderators: |
||
10:00 a.m. - 10:30 a.m. |
Immune System Dynamics in Healthy and Pathological Pregnancies |
|
10:30 a.m. - 11:00 a.m. |
Baby Talk and Baby Steps: Uncovering Microbial-Immune Conversations at the Maternal-Fetal Interface |
|
Calvin J. Hobel, MD “Keynote Lecture” |
||
11:00 a.m. - 11:05 a.m. |
Speaker Introduction |
|
11:05 a.m. - 12:00 p.m. |
Cell-Free Nucleic Acids in Maternal Plasma as Biomarkers of Feto-Placental and Maternal Disease |
|
12:00 p.m. - 1:30 p.m. |
LUNCH |
|
Session III Moderators: |
||
1:30 p.m. - 2:00 p.m. |
Impaired Autophagy and Proteinopathy in Adverse Pregnancy Outcomes |
|
2:00 p.m. - 2:30 p.m. |
Epigenetic Regulation of LncRNA ADAM9 in Preterm Birth Syndrome |
|
Session IV Moderators: |
||
2:30 p.m. - 3:00 p.m. |
Exploring the Physiological Adaptations to Pregnancy - Can it Inform our Understanding Preterm Birth? |
|
3:00 p.m. - 3:30 p.m. |
Modelling Maternal Obesity: Identifying the Mechanism Behind Myometrial Contractile Dysfunction During Parturition |
|
3:30 p.m. - 4:00 p.m. |
BREAK |
|
4:00 p.m. - 4:30 p.m. |
On Target for Novel Therapies? |
|
4:30 p.m. - 5:00 p.m. |
Partnering with Industry for Drug Development in High-Risk Pregnancy |